Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


14.05.2018

2 Ann Neurol
1 Biochemistry
1 BMC Neurol
1 BMC Neurosci
1 J Neural Transm (Vienna)
1 Lancet Neurol
1 Mov Disord
1 Nature
2 Neurology
2 Neurosci Lett
2 PLoS One
3 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. GRUNTZ K, Fuhr P, Meier C, Ruegg S, et al
    Reply to <<Intriguing association of Parkinson disease and epileptic seizures >>.
    Ann Neurol. 2018 May 8. doi: 10.1002/ana.25252.
    PubMed     Text format    

  2. LUKIC S, Bisevac B, Krstic N
    Intriguing association of Parkinson disease and epileptic seizures.
    Ann Neurol. 2018 May 8. doi: 10.1002/ana.25257.
    PubMed     Text format    


    Biochemistry

  3. WERNER-ALLEN JW, Monti S, DuMond JF, Levine RL, et al
    Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of alpha-Synuclein.
    Biochemistry. 2018;57:1462-1474.
    PubMed     Text format     Abstract available


    BMC Neurol

  4. OHYA Y, Osaki M, Sakai S, Kimura S, et al
    A case of hyperparathyroidism-associated parkinsonism successfully treated with cinacalcet hydrochloride, a calcimimetic.
    BMC Neurol. 2018;18:62.
    PubMed     Text format     Abstract available


    BMC Neurosci

  5. MBIYDZENYUY NE, Ninsiima HI, Valladares MB, Pieme CA, et al
    Zinc and linoleic acid pre-treatment attenuates biochemical and histological changes in the midbrain of rats with rotenone-induced Parkinsonism.
    BMC Neurosci. 2018;19:29.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  6. XU W, Zhi Y, Yuan Y, Zhang B, et al
    Correlations between abnormal iron metabolism and non-motor symptoms in Parkinson's disease.
    J Neural Transm (Vienna). 2018 May 10. pii: 10.1007/s00702-018-1889.
    PubMed     Text format     Abstract available


    Lancet Neurol

  7. LEES A, Eyre P, Brown P
    The true face of James Parkinson.
    Lancet Neurol. 2018 Apr 30. pii: S1474-4422(18)30174.
    PubMed     Text format    


    Mov Disord

  8. ORTUNO-LIZARAN I, Beach TG, Serrano GE, Walker DG, et al
    Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
    Mov Disord. 2018 May 8. doi: 10.1002/mds.27392.
    PubMed     Text format     Abstract available


    Nature

  9. WICHMANN T
    Models of Parkinson's disease revisited.
    Nature. 2018;557:169-170.
    PubMed     Text format    


    Neurology

  10. PALMA JA, Mano T
    Central or peripheral autonomic dysfunction in Parkinson disease: Does it matter?
    Neurology. 2018 May 4. pii: WNL.0000000000005624.
    PubMed     Text format    

  11. GROSS A, Racette BA, Camacho-Soto A, Dube U, et al
    Use of medical care biases associations between Parkinson disease and other medical conditions.
    Neurology. 2018 May 9. pii: WNL.0000000000005678.
    PubMed     Text format     Abstract available


    Neurosci Lett

  12. POWELL DW, Blackmore SE, Puppa M, Lester D, et al
    Deep brain stimulation enhances movement complexity during gait in individuals with Parkinson's disease.
    Neurosci Lett. 2018 May 8. pii: S0304-3940(18)30337.
    PubMed     Text format     Abstract available

  13. BEGUM M ET, Sen D
    DOR agonist (SNC-80) exhibits anti-parkinsonian effect via downregulating UPR/oxidative stress signals and inflammatory response in vivo.
    Neurosci Lett. 2018;678:29-36.
    PubMed     Text format     Abstract available


    PLoS One

  14. TURCATO AM, Godi M, Giardini M, Arcolin I, et al
    Abnormal gait pattern emerges during curved trajectories in high-functioning Parkinsonian patients walking in line at normal speed.
    PLoS One. 2018;13:e0197264.
    PubMed     Text format     Abstract available

  15. SALAMA M, Shalash A, Magdy A, Makar M, et al
    Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases.
    PLoS One. 2018;13:e0196436.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  16. NGUYEN M, Krainc D
    LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 May 7. pii: 1717590115.
    PubMed     Text format     Abstract available

  17. REN Q, Ma M, Yang J, Nonaka R, et al
    Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 May 7. pii: 1802179115.
    PubMed     Text format     Abstract available

  18. TURRIANI E, Lazaro DF, Ryazanov S, Leonov A, et al
    Treatment with diphenyl-pyrazole compound anle138b/c reveals that alpha-synuclein protects melanoma cells from autophagic cell death.
    Proc Natl Acad Sci U S A. 2017 Jun 5. pii: 201700200.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: